Publication:
The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial

dc.contributor.authorsOzmen, V.; Ozbas, S.; Karanlik, H.; Muslumanoglu, M.; Igci, A.; Canturk, Z.; Utkan, Z.; Ozaslan, C.; Evrensel, T.; Uras, C.; Aksaz, E.; Soyder, A.; Ugurlu, U. M.; Col, C.; Cabioglu, N.; Bozkurt, B.; Uzunkoy, A.; Sezgin, E.; Gurleyik, G.; Soran, A.
dc.date.accessioned2022-03-12T16:24:29Z
dc.date.accessioned2026-01-11T19:15:39Z
dc.date.available2022-03-12T16:24:29Z
dc.date.issued2019
dc.identifier.doidoiWOS:000491295501127
dc.identifier.eissn1569-8041
dc.identifier.issn0923-7534
dc.identifier.urihttps://hdl.handle.net/11424/226356
dc.identifier.wosWOS:000491295501127
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.relation.ispartofANNALS OF ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.titleANNALS OF ONCOLOGY
oaire.citation.volume30

Files